| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/09/2013 | EP2543372A1 Medicament for the treatment of liver cancer |
| 01/09/2013 | EP2543371A1 Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| 01/09/2013 | EP2542678A1 A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT |
| 01/09/2013 | EP2542590A2 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 01/09/2013 | EP2542588A1 Antibodies against human csf-1r and uses thereof |
| 01/09/2013 | EP2542587A1 Antibodies against human csf-1r and uses thereof |
| 01/09/2013 | EP2542584A2 Methods for treating pancreatic cancer |
| 01/09/2013 | EP2542583A2 Methods for treating breast cancer |
| 01/09/2013 | EP2542578A1 Smoc1, tenascin-c and brain cancers |
| 01/09/2013 | EP2542547A2 Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
| 01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 01/09/2013 | EP2542307A1 Radiotherapy combined with hypoxic cell sensitizers |
| 01/09/2013 | EP2542258A1 Monoclonal antibodies directed to cd52 |
| 01/09/2013 | EP2542251A2 Sandalwood oil and its uses |
| 01/09/2013 | EP2542250A1 Microvesicles (mvs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease |
| 01/09/2013 | EP2542239A1 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 01/09/2013 | EP2542238A1 Compounds for immunoproteasome inhibition |
| 01/09/2013 | EP2542221A2 Concentrated protein formulations and uses thereof |
| 01/09/2013 | EP2542086A1 Compounds and therapeutic uses thereof |
| 01/09/2013 | EP2542081A1 Compounds for treatment of cancer |
| 01/09/2013 | EP2182981B1 Methods and compositions for treatment and diagnosis of fibrosis |
| 01/09/2013 | CN202654436U Antrodia cinnamomea rounded grain structure |
| 01/09/2013 | CN1876657B Stabilization of macrolides |
| 01/09/2013 | CN102869669A Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 01/09/2013 | CN102869658A Modulators of fatty acid amide hydrolase |
| 01/09/2013 | CN102869383A DNA dendrimers as thermal ablation devices |
| 01/09/2013 | CN102869361A N-4 ( - ( ( 3- ( 2 -amino-4 pyrimidinyl) -2 -pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer |
| 01/09/2013 | CN102869358A Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor and an mtor inhibitor for treating cancer |
| 01/09/2013 | CN102869356A Phytocannabinoids in the treatment of cancer |
| 01/09/2013 | CN102864152A Immunostimulation characteristic of oligonucleotide-based compound comprising modified immunostimulation dinucleotide |
| 01/09/2013 | CN102864151A Novel synthetic agonists of tlr9 |
| 01/09/2013 | CN102863950A Deoxyribonucleic acid (DNA) fluorescent probe and preparation method |
| 01/09/2013 | CN102863901A Method for extracting coreopsis tinctoria oil resin by using supercritical or subcritical CO2 |
| 01/09/2013 | CN102863627A Cisplatin complex and preparation method thereof |
| 01/09/2013 | CN102863537A Tumor targeting tumor necrosis factor related apoptosis ligand variant and application thereof |
| 01/09/2013 | CN102863531A CD20-resistant monoclonal antibody as well as preparation method and application thereof |
| 01/09/2013 | CN102863515A B-cell epitope of human melanoma antigen MAGE-A3 and application thereof |
| 01/09/2013 | CN102863514A Peptide vaccines for cancers expressing tumor-associated antigens |
| 01/09/2013 | CN102863506A Four cassane type diterpenoid compounds with antineoplastic activities |
| 01/09/2013 | CN102863484A Fructose glycation mangiferin and preparation method and application thereof |
| 01/09/2013 | CN102863474A Platinum compounds for treating cell proliferative diseases and preparation method and application thereof |
| 01/09/2013 | CN102863472A Combretastatin A-4 analogue, preparation method of combretastatin A-4 analogue and application of combretastatin A-4 analogue in preparing anti-tumor drugs |
| 01/09/2013 | CN102863438A N-(4-(4-(pyridine-2-radical) piperazine-1-radical) pyrimidine-2-radical) amide and salt and preparation method and application thereof |
| 01/09/2013 | CN102863432A Modulators of cftr |
| 01/09/2013 | CN102863397A Quinoxaline keto-amide compound, preparation method and application thereof |
| 01/09/2013 | CN102863388A Tumor targeted drug Combretastatin A4 derivatives |
| 01/09/2013 | CN102863376A N-substituted methyl-3,5-disubstituted benzylidene base-4-piperidone and preparation method and application thereof |
| 01/09/2013 | CN102863338A Compound and medical use thereof |
| 01/09/2013 | CN102861374A Pessulum capable of steadily releasing medicine |
| 01/09/2013 | CN102861340A Intelligent nano delivery system, preparation method and application thereof |
| 01/09/2013 | CN102861338A Combinations of comprising a bcr-abl, c-kit and pdgf-r tyrosine kinase inhibitor used for treating cancer |
| 01/09/2013 | CN102861335A DHEA compositions for treating menopause |
| 01/09/2013 | CN102861334A Tumor signal response active treating nano photodynamic drug carrier and preparation method thereof |
| 01/09/2013 | CN102861312A Plaster for treating osteoarthritis and phymatosis |
| 01/09/2013 | CN102861308A Chinese medicinal preparation for treating esophageal carcinoma and preparation method thereof |
| 01/09/2013 | CN102861304A Traditional Chinese medicine for treating hepatic malignant tumors and preparation method thereof |
| 01/09/2013 | CN102861293A Chinese medicine for treating gastric cancer and preparation method thereof |
| 01/09/2013 | CN102861292A Medicament for treating esophageal cancer and preparation method thereof |
| 01/09/2013 | CN102861291A Chinese herbal medicament for treating esophageal cancer |
| 01/09/2013 | CN102861284A Traditional Chinese medicine compound preparation for treating non-small cell lung cancer and preparation method thereof |
| 01/09/2013 | CN102861262A Chinese medicinal composition for treating esophageal cancer |
| 01/09/2013 | CN102861261A Chinese medicinal preparation for improving living quality of patient suffering from advanced malignant tumor |
| 01/09/2013 | CN102861256A Method for preparing flavone from bamboo leaves |
| 01/09/2013 | CN102861246A Extraction method of corn stigma anti-cancer substance |
| 01/09/2013 | CN102861239A Powdery Chinese patent medicine externally applied to feet of patients for treating tuberculosis and lung tumor |
| 01/09/2013 | CN102861236A Anti-tumor preparation made of pure traditional Chinese medicines |
| 01/09/2013 | CN102861193A Traditional Chinese medicine composition for treating gastric cancer |
| 01/09/2013 | CN102861190A Traditional Chinese medicine formula for treating esophageal carcinoma |
| 01/09/2013 | CN102861140A Method for preparing total paeony glycoside |
| 01/09/2013 | CN102861128A Application of effective site of salvianolic acids to preparation of preparations for treating skin diseases |
| 01/09/2013 | CN102861112A Kosteletzkya virginica lignan extract and preparation method and application thereof |
| 01/09/2013 | CN102861109A Cyrtomium fortunei extract and preparation method and application thereof |
| 01/09/2013 | CN102861107A DC-CIK (dendritic cells-cytokine-induced killers) cell treatment composition |
| 01/09/2013 | CN102861103A Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure |
| 01/09/2013 | CN102861099A Application of Houttuynoid D in medicine for treating endometrial cancer |
| 01/09/2013 | CN102861097A Application of Houttuynoid E in medicine for treating bladder cancer |
| 01/09/2013 | CN102861096A Application of Houttuynoid E in medicine for treating cervical cancer |
| 01/09/2013 | CN102861094A Application of Houttuynoid E in medicine for treating bile duct cancer |
| 01/09/2013 | CN102861093A Application of Houttuynoid B in medicine for treating colorectal cancer |
| 01/09/2013 | CN102861092A Application of Houttuynoid C in medicine for treating lung cancer |
| 01/09/2013 | CN102861091A Application of Houttuynoid C in anti-lung cancerometastasis medicine |
| 01/09/2013 | CN102861090A Application of Houttuynoid C in medicine for treating bile duct cancer |
| 01/09/2013 | CN102861089A Application of Houttuynoid B in medicine for treating liver cancer |
| 01/09/2013 | CN102861086A Application of Houttuynoid E in medicine for treating ovarian cancer |
| 01/09/2013 | CN102861084A Application of Houttuynoid D in medicine for treating ileocecum cancer |
| 01/09/2013 | CN102861081A Application of Houttuynoid C in medicine for treating skin cancer |
| 01/09/2013 | CN102861080A Application of Houttuynoid C in medicine for treating nasopharynx cancer |
| 01/09/2013 | CN102861079A Application of Houttuynoid B in medicine for treating skin cancer |
| 01/09/2013 | CN102861078A Application of Houttuynoid D in medicine for treating prostatic cancer |
| 01/09/2013 | CN102861077A Application of Houttuynoid D in medicine for treating cervical cancer |
| 01/09/2013 | CN102861075A Application of Houttuynoid B in medicine for treating gastric cancer |
| 01/09/2013 | CN102861074A Application of Houttuynoid B in medicine for treating bladder cancer |
| 01/09/2013 | CN102861073A Application of Houttuynoid A in medicine for treating colorectal cancer |
| 01/09/2013 | CN102861071A Application of Houttuynoid A in medicine for treating gastric cancer |
| 01/09/2013 | CN102861070A Application of Houttuynoid E in medicine for treating tongue cancer |
| 01/09/2013 | CN102861069A Application of Houttuynoid B in medicine for treating laryngocarcinoma |
| 01/09/2013 | CN102861065A Application of Houttuynoid E in medicine for treating gastric cancer |
| 01/09/2013 | CN102861064A Application of Houttuynoid E in medicine for treating laryngocarcinoma |
| 01/09/2013 | CN102861062A Application of Houttuynoid C in endometrial cancer treatment medicine |
| 01/09/2013 | CN102861061A Application of Houttuynoid B in cholangiocarcinoma treatment medicine |